May 11, 2026 06:30AM
Mar 5, 2026 06:30AM
Mar 5, 2026 06:30AM
Jan 9, 2026 06:30AM
Jan 9, 2026 06:30AM
Nov 3, 2025 06:30AM
Aug 15, 2025 07:43AM Jefferies Assumes Liquidia Technologies (LQDA) at Buy
Aug 12, 2025 06:30AM
Jun 23, 2025 04:34PM
Jun 23, 2025 04:34PM
Jun 2, 2025 01:38PM
Jun 2, 2025 01:00PM
Jun 2, 2025 06:31AM
Jun 2, 2025 06:30AM Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD
May 28, 2025 08:01AM
May 28, 2025 07:27AM
May 27, 2025 03:42PM
May 27, 2025 04:27AM
May 27, 2025 04:20AM
May 23, 2025 02:29PM
May 23, 2025 02:28PM U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disea
May 21, 2025 05:13AM
May 12, 2025 01:36PM
May 12, 2025 06:00AM
May 8, 2025 06:30AM
May 5, 2025 06:52AM
May 2, 2025 05:28PM
Mar 28, 2025 09:31AM Liquidia Technologies (LQDA) Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA (treprostinil) Inhalation Powder
Mar 28, 2025 09:30AM
Mar 27, 2025 08:00AM
Mar 19, 2025 06:30AM
Mar 18, 2025 08:00AM
Nov 13, 2024 06:30AM
Oct 8, 2024 06:14AM
Oct 8, 2024 06:09AM LifeSci Capital Reiterates Outperform Rating on Liquidia Technologies (LQDA)
Oct 7, 2024 01:01PM
Oct 7, 2024 10:00AM
Sep 30, 2024 08:00AM
Sep 16, 2024 09:42AM
Sep 16, 2024 09:41AM
Sep 11, 2024 08:27AM
Sep 11, 2024 08:26AM Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing Agreement
Aug 22, 2024 06:33AM
Aug 22, 2024 06:00AM
Aug 20, 2024 06:12AM
Aug 20, 2024 04:56AM
Aug 20, 2024 04:53AM
Aug 20, 2024 04:51AM
Aug 19, 2024 04:01PM Liquidia Technologies (LQDA) PT Lowered to $17 at Jefferies
Aug 19, 2024 11:15AM

322,234 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All